4:21 PM ET
10-Q
Financial Results
Decoy Therapeutics Q3 2026 Results: Net Loss of $2.99M, Loss Widens
Decoy Therapeutics Inc. reported a net loss of $7.59 million for the nine months ended September 30, 2026, compared to a $3.54 million loss in the prior year period, driven by a significant increase in research and development expenses. The company recognized $535,059 in grant revenue during the period and maintains a cash balance of approximately $8.17 million as of September 30, 2026.
- Key figure
- Net loss $2.99M